Source comparison
MK-677 Dosing Protocols: Research vs Practical Comparison
| Protocol Type | Dose | Timing | Duration | Sleep Outcome | Practical Constraints | Professional Assessment ||—|—|—|—|—|—|| Clinical Trial Standard | 25mg daily | 90 min pre-sleep | 8+ weeks | 50% increase in Stage 4 sleep, 20% increase in REM within 7 days |
This comparison does not assign a generated winner or score.
- | Protocol Type | Dose | Timing | Duration | Sleep Outcome | Practical Constraints | Professional Assessment ||—|—|—|—|—|—|| Clinical Trial Standard | 25mg daily | 90 min pre-sleep | 8+ weeks | 50% increase in Stage 4 sleep, 20% increase in REM within 7 days | Requires fasted or semi-fasted evening state; may cause transient water retention in first 10 days | Gold standard for efficacy but demands strict adherence to dosing window and dietary timing. Best suited for users with consistent evening schedules || Conservative Titration | 12.5mg daily for 7 days, then 25mg | 60–90 min pre-sleep | 8+ weeks | Comparable sleep architecture improvement with reduced initial side effects | Slower onset of maximum benefit (14–21 days vs 7 days) | Preferred for first-time users or those with known sensitivity to GH secretagogues. Minimises dropout risk from acute side effects || Split-Dose Protocol | 12.5mg AM, 12.5mg PM | AM dose with breakfast, PM dose 90 min pre-sleep | 8+ weeks | Maintains eleva